Fmoc-L-Cpa-OH is an Fmoc-protected, L-configured amino acid derivative in which the side chain corresponds to Cpa (cysteine-proline-like amino acid) and is appended to the α-amino acid backbone bearing a free carboxylic acid. The molecule contains an Fmoc (9H-fluoren-9-ylmethoxycarbonyl) carbamate on the α-amino group, while the carboxyl group remains unprotected as a carboxylic acid, providing a handle for coupling and subsequent deprotection-controlled peptide assembly. In peptide chemistry and solid-phase peptide synthesis workflows, it functions as a protected amino acid building block that supports stepwise incorporation of the Cpa side chain into peptide sequences and enables structural studies, conjugation precursor preparation, or analytical method development using defined amino acid composition.
CAT No: CP25614
CAS No:214750-76-2
Synonyms/Alias:214750-76-2;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyclopropylpropanoicacid;Fmoc-L-Cyclopropylalanine;(2S)-3-cyclopropyl-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}propanoicacid;N-Fmoc-cyclopropylalanine;AmbotzFAA1764;AC1ODUO4;Fmoc-beta-cyclopropyl-Ala-OH;SCHEMBL5324353;MolPort-003-725-634;ZINC2569788;CF-732;AKOS015837219;AKOS015949966;FL576-1;AK162664;AM003370;AM020191;TL8006223;3B3-077935;(2S)-3-cyclopropyl-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoicacid
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-beta-cyclopropyl-L-alanine
Fmoc-L-Cpa-OH is an Fmoc-protected, L-configured amino acid derivative in which the side chain is built around a cyclic, sulfur-containing heterocycle (Cpa, cysteine-derived pyran-like scaffold) that provides defined stereochemical and conformational features for peptide and peptidomimetic design. The molecule bears an N-(9H-fluorenylmethoxycarbonyl) protecting group that suppresses unselective amide bond formation during solid-phase or solution-phase coupling, while the free carboxylic acid enables controlled C-terminal activation and coupling chemistry. The side-chain heterocycle and associated sulfur functionality can participate in nucleophilic and electrophilic transformations under appropriate conditions, supporting downstream derivatization and scaffold diversification. As a chiral amino acid building block, Fmoc-L-Cpa-OH is commonly handled as a protected intermediate for constructing sequence-defined peptides and for preparing functional analogs that retain stereochemical integrity through synthetic steps.
1. Peptide Synthesis
Fmoc-L-Cpa-OH is used in peptide building block workflows where Fmoc protection enables stepwise N-terminal deprotection and subsequent peptide coupling on solid supports or in solution-phase assembly. The free carboxylic acid allows activation to form amide bonds, while the L-stereocenter supports stereochemically consistent incorporation into growing peptide chains. The sulfur-containing cyclic side chain can influence local conformations and may affect coupling microenvironments, making it relevant for constructing peptides that require defined geometry or stability. The resulting Cpa-containing sequences can be carried forward into peptide analog libraries, biochemical probes, or structure-focused optimization studies that depend on reliable protected amino acid chemistry.
2. Peptidomimetics And SAR Studies
Fmoc-L-Cpa-OH is applied in peptidomimetic construction and structure-activity relationship studies where incorporation of a conformationally constrained, sulfur-containing side chain supports scaffold tuning beyond standard proteinogenic amino acids. The Fmoc group provides compatibility with protected amino acid strategies, enabling controlled synthesis of analogs that preserve the chiral configuration while varying adjacent residues. Carboxyl activation and amide formation support rapid generation of derivative series for SAR studies, including analogs that probe how side-chain electronics and ring constraints modulate molecular recognition. Downstream transformations of the sulfur-containing moiety can be used to access oxidized, substituted, or functionalized variants that broaden the chemical space for medicinal chemistry and chemical biology research.
3. Side-Chain Functionalization
Fmoc-L-Cpa-OH serves as a chiral amino acid intermediate for side-chain functionalization routes that target the sulfur-containing heterocycle for chemical modification. The protected N-terminus (Fmoc) helps maintain chemoselectivity during early-stage derivatization steps, while the free carboxylic acid can be temporarily converted to activated derivatives if coupling or further elaboration is required. The heterocycle can potentially undergo targeted transformations that introduce additional functional handles, enabling orthogonal reactivity for subsequent conjugation or crosslinking strategies. The ability to maintain stereochemical integrity while modifying the side chain supports downstream generation of functionalized peptide fragments, labeling reagents, and intermediate scaffolds for specialty chemical production.
4. Chemical Biology Probes
Fmoc-L-Cpa-OH is utilized in chemical biology research for preparing peptide-based probes that require defined stereochemistry and a side-chain motif capable of participating in selective chemical interactions. The Fmoc-protected amino acid format supports incorporation into sequence-defined constructs, while the carboxylic acid enables formation of amide linkages that anchor the probe scaffold to peptide carriers or targeting motifs. The sulfur-containing cyclic side chain can provide a distinct physicochemical profile that may influence binding modes, stability, or reactivity in assay environments. Synthesized Cpa-containing probe molecules can be used as molecular tools for interrogating biomolecular interactions, enabling downstream studies that rely on controlled peptide construction and functional group placement.
5. Pharmaceutical Intermediate Preparation
Fmoc-L-Cpa-OH can be employed as a chiral intermediate in pharmaceutical manufacturing and fine chemical synthesis contexts where protected amino acid derivatives are required for building block supply. The Fmoc-protected amine supports reproducible peptide coupling chemistry, and the free carboxylic acid provides a handle for activation steps that convert the chiral amino acid into downstream intermediates for larger synthetic sequences. The presence of a sulfur-containing heterocycle enables access to specialized analogs used in process development for peptide-like or peptidomimetic structures. The compound's protected amino acid identity makes it suitable for controlled intermediate preparation where stereochemical fidelity and functional group compatibility are central to scalable synthesis planning.
6. Process Chemistry Intermediate
Fmoc-L-Cpa-OH is relevant to process chemistry intermediate preparation for manufacturing routes that require orthogonally protected amino acid building blocks with predictable deprotection and coupling behavior. The Fmoc group provides a well-established protection strategy for N-terminal control, supporting stepwise assembly while minimizing side reactions from the amino functionality. The carboxylic acid enables conversion into activated forms for amide bond formation, supporting integration into continuous or batch synthetic workflows that generate peptide fragments and analogs. The chiral, sulfur-containing side chain can be carried through multi-step sequences as a stable intermediate, enabling downstream formation of functionalized peptide scaffolds and specialty chemical intermediates with defined stereochemistry.
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.